Atlas Trials

Study Of AG-013736 In Patients With 131I-Refractory Thyroid Cancer

Clinical trial NCT00389441 · COMPLETED

Trial details

NCT number
NCT00389441
Sponsor
Pfizer
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Thyroid Neoplasms
Start date
2006-12-01
Primary completion
2012-09-01
Enrollment
52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.